The global smart syringe market size reached US$ 8.18 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.39 Billion by 2027, exhibiting a growth rate (CAGR) of 8.15% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A smart syringe is a medical device engineered with safety mechanisms to prevent reuse and regulate unsafe injection practices. It is incorporated with a read and write chip with preset parameters, ranges, and usage tracking. It is commonly available in variants of auto-disable (AD), passive safety, and active safety syringes. It aids in treating patients with critical disorders and conditions, such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and diabetes. It is used for vaccination, drug delivery, and blood specimen collection. As a result, it is utilized in hospitals, clinics, diagnostics, and vaccination centers across the globe.
Smart Syringe Market Trends:
The increasing prevalence of chronic diseases and viral infections among the masses represents one of the major factors positively influencing the demand for smart syringes around the world. It can also be attributed to the growing aging population, which is more prone to severe medical diseases. Moreover, the expanding number of blood-borne infections among the masses is favoring the market growth. In addition, the rising demand for self-injecting medicines is contributing to the market growth. Apart from this, increasing concerns about needle stick injuries and the rising awareness about safe injection practices are offering lucrative growth opportunities to leading players operating in the industry. Furthermore, the expanding number of births and the growing prevalence of various pediatric diseases among adolescents are creating a positive outlook for the market. Additionally, product manufacturers are introducing small-sized, convenient, lightweight with touch screens and Wi-Fi-enabled solutions for easy monitoring. Besides this, rising investments in improving healthcare infrastructure and medical services and extensive research and development (R&D) activities are expected to propel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global smart syringe market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, age group, application and end user.
Breakup by Product:
Active Safety Syringes
Passive Safety Syringes
Breakup by Age Group:
Breakup by Application:
Blood Specimen Collection
Breakup by End User:
Hospitals and HMOs
Family Practices (Physicians)
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being AdvaCare Pharma, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Merit Medical Systems Inc., Nipro Corporation, Numedico Technologies Pty Ltd., Retractable Technologies Inc. and Terumo Corporation.
Key questions answered in this report:
How has the global smart syringe market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global smart syringe market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the age group?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global smart syringe market and who are the key players?
What is the degree of competition in the industry?